Company intelligence / Profile preview

CMED HIFU Development

Ownership: Private
Development stage: Commercial

Overview

China Medical Technologies developed and commercialized High Intensity Focused Ultrasound (HIFU) devices for non-invasive ablation of solid and benign tumors. Clinical studies demonstrated efficacy in ablating liver malignancies and other solid cancers, with some trials showing improved survival when combined with other therapies such as TACE for liver cancer. The company sold its entire HIFU tumor therapy system business to Chengxuan International Ltd. in December 2008 due to adverse market conditions and a strategic shift toward IVD products.

Therapeutic areas: Oncology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on CMED HIFU Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CMED HIFU Development.

Explore the full profile